Medical Care

Global Pharmacogenomics Services Market Research Report 2025

The global market for Pharmacogenomics Services was valued at US$ 1444 million in the year 2024 and is projected to reach a revised size of US$ 2062 million by 2031, growing at a CAGR of 5.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacogenomics Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogenomics Services.
The Pharmacogenomics Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacogenomics Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacogenomics Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Admera Health, LLC
Mesa Laboratories, Inc.
Dynamic DNA Laboratories
F. Hoffmann-La Roche Ltd.
GeneOmbio Technologies Pvt Ltd.
Exact Sciences Corporation
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
OmeCare
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Precipio
23andMe, Inc.
OneOme, LLC
DiaCarta, Inc.
OPKO Health
Segment by Type
Genotyping
SNP Identification
Pharmacogenetic Testing
Others
Segment by Application
Oncology
Infectious Diseases
Psychiatry
Cardiovascular
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacogenomics Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacogenomics Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genotyping
1.2.3 SNP Identification
1.2.4 Pharmacogenetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmacogenomics Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Infectious Diseases
1.3.4 Psychiatry
1.3.5 Cardiovascular
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacogenomics Services Market Perspective (2020-2031)
2.2 Global Pharmacogenomics Services Growth Trends by Region
2.2.1 Global Pharmacogenomics Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmacogenomics Services Historic Market Size by Region (2020-2025)
2.2.3 Pharmacogenomics Services Forecasted Market Size by Region (2026-2031)
2.3 Pharmacogenomics Services Market Dynamics
2.3.1 Pharmacogenomics Services Industry Trends
2.3.2 Pharmacogenomics Services Market Drivers
2.3.3 Pharmacogenomics Services Market Challenges
2.3.4 Pharmacogenomics Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacogenomics Services Players by Revenue
3.1.1 Global Top Pharmacogenomics Services Players by Revenue (2020-2025)
3.1.2 Global Pharmacogenomics Services Revenue Market Share by Players (2020-2025)
3.2 Global Pharmacogenomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmacogenomics Services Revenue
3.4 Global Pharmacogenomics Services Market Concentration Ratio
3.4.1 Global Pharmacogenomics Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics Services Revenue in 2024
3.5 Global Key Players of Pharmacogenomics Services Head office and Area Served
3.6 Global Key Players of Pharmacogenomics Services, Product and Application
3.7 Global Key Players of Pharmacogenomics Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenomics Services Breakdown Data by Type
4.1 Global Pharmacogenomics Services Historic Market Size by Type (2020-2025)
4.2 Global Pharmacogenomics Services Forecasted Market Size by Type (2026-2031)
5 Pharmacogenomics Services Breakdown Data by Application
5.1 Global Pharmacogenomics Services Historic Market Size by Application (2020-2025)
5.2 Global Pharmacogenomics Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmacogenomics Services Market Size (2020-2031)
6.2 North America Pharmacogenomics Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmacogenomics Services Market Size by Country (2020-2025)
6.4 North America Pharmacogenomics Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacogenomics Services Market Size (2020-2031)
7.2 Europe Pharmacogenomics Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmacogenomics Services Market Size by Country (2020-2025)
7.4 Europe Pharmacogenomics Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacogenomics Services Market Size (2020-2031)
8.2 Asia-Pacific Pharmacogenomics Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmacogenomics Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmacogenomics Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacogenomics Services Market Size (2020-2031)
9.2 Latin America Pharmacogenomics Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmacogenomics Services Market Size by Country (2020-2025)
9.4 Latin America Pharmacogenomics Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacogenomics Services Market Size (2020-2031)
10.2 Middle East & Africa Pharmacogenomics Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmacogenomics Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmacogenomics Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Pharmacogenomics Services Introduction
11.1.4 Abbott Laboratories Revenue in Pharmacogenomics Services Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Admera Health, LLC
11.2.1 Admera Health, LLC Company Details
11.2.2 Admera Health, LLC Business Overview
11.2.3 Admera Health, LLC Pharmacogenomics Services Introduction
11.2.4 Admera Health, LLC Revenue in Pharmacogenomics Services Business (2020-2025)
11.2.5 Admera Health, LLC Recent Development
11.3 Mesa Laboratories, Inc.
11.3.1 Mesa Laboratories, Inc. Company Details
11.3.2 Mesa Laboratories, Inc. Business Overview
11.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Introduction
11.3.4 Mesa Laboratories, Inc. Revenue in Pharmacogenomics Services Business (2020-2025)
11.3.5 Mesa Laboratories, Inc. Recent Development
11.4 Dynamic DNA Laboratories
11.4.1 Dynamic DNA Laboratories Company Details
11.4.2 Dynamic DNA Laboratories Business Overview
11.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Introduction
11.4.4 Dynamic DNA Laboratories Revenue in Pharmacogenomics Services Business (2020-2025)
11.4.5 Dynamic DNA Laboratories Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Pharmacogenomics Services Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 GeneOmbio Technologies Pvt Ltd.
11.6.1 GeneOmbio Technologies Pvt Ltd. Company Details
11.6.2 GeneOmbio Technologies Pvt Ltd. Business Overview
11.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Introduction
11.6.4 GeneOmbio Technologies Pvt Ltd. Revenue in Pharmacogenomics Services Business (2020-2025)
11.6.5 GeneOmbio Technologies Pvt Ltd. Recent Development
11.7 Exact Sciences Corporation
11.7.1 Exact Sciences Corporation Company Details
11.7.2 Exact Sciences Corporation Business Overview
11.7.3 Exact Sciences Corporation Pharmacogenomics Services Introduction
11.7.4 Exact Sciences Corporation Revenue in Pharmacogenomics Services Business (2020-2025)
11.7.5 Exact Sciences Corporation Recent Development
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Details
11.8.2 Illumina, Inc. Business Overview
11.8.3 Illumina, Inc. Pharmacogenomics Services Introduction
11.8.4 Illumina, Inc. Revenue in Pharmacogenomics Services Business (2020-2025)
11.8.5 Illumina, Inc. Recent Development
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Company Details
11.9.2 Laboratory Corporation of America Holdings Business Overview
11.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Introduction
11.9.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics Services Business (2020-2025)
11.9.5 Laboratory Corporation of America Holdings Recent Development
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Details
11.10.2 Myriad Genetics, Inc. Business Overview
11.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Introduction
11.10.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics Services Business (2020-2025)
11.10.5 Myriad Genetics, Inc. Recent Development
11.11 OmeCare
11.11.1 OmeCare Company Details
11.11.2 OmeCare Business Overview
11.11.3 OmeCare Pharmacogenomics Services Introduction
11.11.4 OmeCare Revenue in Pharmacogenomics Services Business (2020-2025)
11.11.5 OmeCare Recent Development
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Details
11.12.2 QIAGEN N.V. Business Overview
11.12.3 QIAGEN N.V. Pharmacogenomics Services Introduction
11.12.4 QIAGEN N.V. Revenue in Pharmacogenomics Services Business (2020-2025)
11.12.5 QIAGEN N.V. Recent Development
11.13 Quest Diagnostics Incorporated
11.13.1 Quest Diagnostics Incorporated Company Details
11.13.2 Quest Diagnostics Incorporated Business Overview
11.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Introduction
11.13.4 Quest Diagnostics Incorporated Revenue in Pharmacogenomics Services Business (2020-2025)
11.13.5 Quest Diagnostics Incorporated Recent Development
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Details
11.14.2 Thermo Fisher Scientific Inc. Business Overview
11.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Introduction
11.14.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Services Business (2020-2025)
11.14.5 Thermo Fisher Scientific Inc. Recent Development
11.15 Precipio
11.15.1 Precipio Company Details
11.15.2 Precipio Business Overview
11.15.3 Precipio Pharmacogenomics Services Introduction
11.15.4 Precipio Revenue in Pharmacogenomics Services Business (2020-2025)
11.15.5 Precipio Recent Development
11.16 23andMe, Inc.
11.16.1 23andMe, Inc. Company Details
11.16.2 23andMe, Inc. Business Overview
11.16.3 23andMe, Inc. Pharmacogenomics Services Introduction
11.16.4 23andMe, Inc. Revenue in Pharmacogenomics Services Business (2020-2025)
11.16.5 23andMe, Inc. Recent Development
11.17 OneOme, LLC
11.17.1 OneOme, LLC Company Details
11.17.2 OneOme, LLC Business Overview
11.17.3 OneOme, LLC Pharmacogenomics Services Introduction
11.17.4 OneOme, LLC Revenue in Pharmacogenomics Services Business (2020-2025)
11.17.5 OneOme, LLC Recent Development
11.18 DiaCarta, Inc.
11.18.1 DiaCarta, Inc. Company Details
11.18.2 DiaCarta, Inc. Business Overview
11.18.3 DiaCarta, Inc. Pharmacogenomics Services Introduction
11.18.4 DiaCarta, Inc. Revenue in Pharmacogenomics Services Business (2020-2025)
11.18.5 DiaCarta, Inc. Recent Development
11.19 OPKO Health
11.19.1 OPKO Health Company Details
11.19.2 OPKO Health Business Overview
11.19.3 OPKO Health Pharmacogenomics Services Introduction
11.19.4 OPKO Health Revenue in Pharmacogenomics Services Business (2020-2025)
11.19.5 OPKO Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pharmacogenomics Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genotyping
Table 3. Key Players of SNP Identification
Table 4. Key Players of Pharmacogenetic Testing
Table 5. Key Players of Others
Table 6. Global Pharmacogenomics Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pharmacogenomics Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pharmacogenomics Services Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pharmacogenomics Services Market Share by Region (2020-2025)
Table 10. Global Pharmacogenomics Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pharmacogenomics Services Market Share by Region (2026-2031)
Table 12. Pharmacogenomics Services Market Trends
Table 13. Pharmacogenomics Services Market Drivers
Table 14. Pharmacogenomics Services Market Challenges
Table 15. Pharmacogenomics Services Market Restraints
Table 16. Global Pharmacogenomics Services Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pharmacogenomics Services Market Share by Players (2020-2025)
Table 18. Global Top Pharmacogenomics Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Services as of 2024)
Table 19. Ranking of Global Top Pharmacogenomics Services Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pharmacogenomics Services Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pharmacogenomics Services, Headquarters and Area Served
Table 22. Global Key Players of Pharmacogenomics Services, Product and Application
Table 23. Global Key Players of Pharmacogenomics Services, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmacogenomics Services Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pharmacogenomics Services Revenue Market Share by Type (2020-2025)
Table 27. Global Pharmacogenomics Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pharmacogenomics Services Revenue Market Share by Type (2026-2031)
Table 29. Global Pharmacogenomics Services Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pharmacogenomics Services Revenue Market Share by Application (2020-2025)
Table 31. Global Pharmacogenomics Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pharmacogenomics Services Revenue Market Share by Application (2026-2031)
Table 33. North America Pharmacogenomics Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pharmacogenomics Services Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pharmacogenomics Services Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pharmacogenomics Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pharmacogenomics Services Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pharmacogenomics Services Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pharmacogenomics Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pharmacogenomics Services Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pharmacogenomics Services Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pharmacogenomics Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pharmacogenomics Services Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharmacogenomics Services Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pharmacogenomics Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pharmacogenomics Services Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pharmacogenomics Services Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Pharmacogenomics Services Product
Table 51. Abbott Laboratories Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Admera Health, LLC Company Details
Table 54. Admera Health, LLC Business Overview
Table 55. Admera Health, LLC Pharmacogenomics Services Product
Table 56. Admera Health, LLC Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 57. Admera Health, LLC Recent Development
Table 58. Mesa Laboratories, Inc. Company Details
Table 59. Mesa Laboratories, Inc. Business Overview
Table 60. Mesa Laboratories, Inc. Pharmacogenomics Services Product
Table 61. Mesa Laboratories, Inc. Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 62. Mesa Laboratories, Inc. Recent Development
Table 63. Dynamic DNA Laboratories Company Details
Table 64. Dynamic DNA Laboratories Business Overview
Table 65. Dynamic DNA Laboratories Pharmacogenomics Services Product
Table 66. Dynamic DNA Laboratories Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 67. Dynamic DNA Laboratories Recent Development
Table 68. F. Hoffmann-La Roche Ltd. Company Details
Table 69. F. Hoffmann-La Roche Ltd. Business Overview
Table 70. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product
Table 71. F. Hoffmann-La Roche Ltd. Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 72. F. Hoffmann-La Roche Ltd. Recent Development
Table 73. GeneOmbio Technologies Pvt Ltd. Company Details
Table 74. GeneOmbio Technologies Pvt Ltd. Business Overview
Table 75. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product
Table 76. GeneOmbio Technologies Pvt Ltd. Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 77. GeneOmbio Technologies Pvt Ltd. Recent Development
Table 78. Exact Sciences Corporation Company Details
Table 79. Exact Sciences Corporation Business Overview
Table 80. Exact Sciences Corporation Pharmacogenomics Services Product
Table 81. Exact Sciences Corporation Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 82. Exact Sciences Corporation Recent Development
Table 83. Illumina, Inc. Company Details
Table 84. Illumina, Inc. Business Overview
Table 85. Illumina, Inc. Pharmacogenomics Services Product
Table 86. Illumina, Inc. Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 87. Illumina, Inc. Recent Development
Table 88. Laboratory Corporation of America Holdings Company Details
Table 89. Laboratory Corporation of America Holdings Business Overview
Table 90. Laboratory Corporation of America Holdings Pharmacogenomics Services Product
Table 91. Laboratory Corporation of America Holdings Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 92. Laboratory Corporation of America Holdings Recent Development
Table 93. Myriad Genetics, Inc. Company Details
Table 94. Myriad Genetics, Inc. Business Overview
Table 95. Myriad Genetics, Inc. Pharmacogenomics Services Product
Table 96. Myriad Genetics, Inc. Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 97. Myriad Genetics, Inc. Recent Development
Table 98. OmeCare Company Details
Table 99. OmeCare Business Overview
Table 100. OmeCare Pharmacogenomics Services Product
Table 101. OmeCare Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 102. OmeCare Recent Development
Table 103. QIAGEN N.V. Company Details
Table 104. QIAGEN N.V. Business Overview
Table 105. QIAGEN N.V. Pharmacogenomics Services Product
Table 106. QIAGEN N.V. Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 107. QIAGEN N.V. Recent Development
Table 108. Quest Diagnostics Incorporated Company Details
Table 109. Quest Diagnostics Incorporated Business Overview
Table 110. Quest Diagnostics Incorporated Pharmacogenomics Services Product
Table 111. Quest Diagnostics Incorporated Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 112. Quest Diagnostics Incorporated Recent Development
Table 113. Thermo Fisher Scientific Inc. Company Details
Table 114. Thermo Fisher Scientific Inc. Business Overview
Table 115. Thermo Fisher Scientific Inc. Pharmacogenomics Services Product
Table 116. Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 117. Thermo Fisher Scientific Inc. Recent Development
Table 118. Precipio Company Details
Table 119. Precipio Business Overview
Table 120. Precipio Pharmacogenomics Services Product
Table 121. Precipio Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 122. Precipio Recent Development
Table 123. 23andMe, Inc. Company Details
Table 124. 23andMe, Inc. Business Overview
Table 125. 23andMe, Inc. Pharmacogenomics Services Product
Table 126. 23andMe, Inc. Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 127. 23andMe, Inc. Recent Development
Table 128. OneOme, LLC Company Details
Table 129. OneOme, LLC Business Overview
Table 130. OneOme, LLC Pharmacogenomics Services Product
Table 131. OneOme, LLC Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 132. OneOme, LLC Recent Development
Table 133. DiaCarta, Inc. Company Details
Table 134. DiaCarta, Inc. Business Overview
Table 135. DiaCarta, Inc. Pharmacogenomics Services Product
Table 136. DiaCarta, Inc. Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 137. DiaCarta, Inc. Recent Development
Table 138. OPKO Health Company Details
Table 139. OPKO Health Business Overview
Table 140. OPKO Health Pharmacogenomics Services Product
Table 141. OPKO Health Revenue in Pharmacogenomics Services Business (2020-2025) & (US$ Million)
Table 142. OPKO Health Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report


List of Figures
Figure 1. Pharmacogenomics Services Picture
Figure 2. Global Pharmacogenomics Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmacogenomics Services Market Share by Type: 2024 VS 2031
Figure 4. Genotyping Features
Figure 5. SNP Identification Features
Figure 6. Pharmacogenetic Testing Features
Figure 7. Others Features
Figure 8. Global Pharmacogenomics Services Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pharmacogenomics Services Market Share by Application: 2024 VS 2031
Figure 10. Oncology Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. Psychiatry Case Studies
Figure 13. Cardiovascular Case Studies
Figure 14. Others Case Studies
Figure 15. Pharmacogenomics Services Report Years Considered
Figure 16. Global Pharmacogenomics Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Pharmacogenomics Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Pharmacogenomics Services Market Share by Region: 2024 VS 2031
Figure 19. Global Pharmacogenomics Services Market Share by Players in 2024
Figure 20. Global Top Pharmacogenomics Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Services as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Pharmacogenomics Services Revenue in 2024
Figure 22. North America Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Pharmacogenomics Services Market Share by Country (2020-2031)
Figure 24. United States Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Pharmacogenomics Services Market Share by Country (2020-2031)
Figure 28. Germany Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Pharmacogenomics Services Market Share by Region (2020-2031)
Figure 36. China Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Pharmacogenomics Services Market Share by Country (2020-2031)
Figure 44. Mexico Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Pharmacogenomics Services Market Share by Country (2020-2031)
Figure 48. Turkey Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Pharmacogenomics Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 52. Admera Health, LLC Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 53. Mesa Laboratories, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 54. Dynamic DNA Laboratories Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 55. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 56. GeneOmbio Technologies Pvt Ltd. Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 57. Exact Sciences Corporation Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 58. Illumina, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 59. Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 60. Myriad Genetics, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 61. OmeCare Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 62. QIAGEN N.V. Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 63. Quest Diagnostics Incorporated Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 64. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 65. Precipio Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 66. 23andMe, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 67. OneOme, LLC Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 68. DiaCarta, Inc. Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 69. OPKO Health Revenue Growth Rate in Pharmacogenomics Services Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies